Voyager Therapeutics Announces Third Quarter 2022 Conference Call and Webcast

November 1, 2022

https://www.globenewswire.com/news-release/2022/11/01/2545346/36461/en/Voyager-Therapeutics-Announces-Third-Quarter-2022-Conference-Call-and-Webcast.html

CAMBRIDGE, Mass., Nov. 01, 2022 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (Nasdaq:VYGR), a gene therapy and neuroscience company developing life-changing treatments and next-generation adeno-associated virus (AAV) capsids, today announced it will report third quarter 2022 financial and operating results before the market opens on Tuesday, November 8, 2022. Subsequently, the Company will host a live conference call and webcast at 8:30 a.m. ET to review its financial and operating results.

Read more at globenewswire.com

Related news for (VYGR)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.